Table 3. Adjusted Proportions and Risk Differences for Uncontrolled and Untreated CVRFs.
| CVRF | Uncontrolled CVRF | Untreated CVRF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. with recorded value | Adjusted, % (95% CI) | No. uncontrolled | Adjusted, % (95% CI) | |||||||
| Proportion uncontrolled, ASCVD−/ADT− [reference]a | Risk differenceb | Proportion untreated, ASCVD−/ADT− [reference]c | Risk differenceb | |||||||
| ASCVD+/ADT- | ASCVD+/ADT+ | ASCVD-/ADT+ | ASCVD+/ADT− | ASCVD+/ADT+ | ASCVD−/ADT+ | |||||
| Blood pressure | 89 572 | 35.8 (35.4 to 36.3) | −4.6 (−5.6 to −3.6) | −4.7 (−6.2 to −3.1) | 2.6 (1.7 to 3.6) | 31 960 | 24.5 (23.8 to 25.1) | −15.9 (−17.1 to −14.7) | −18.1 (−19.7 to −16.4) | −4.3 (−5.5 to −3.0) |
| Cholesterol | 85 243 | 21.7 (21.3 to 22.1) | −8.9 (−9.7 to −8.2) | −9.5 (−10.5 to −8.4) | −1.6 (−2.4 to −0.8) | 16 879 | 50.8 (49.9 to 51.8) | −32.0 (−34.4 to −29.5) | −29.4 (−33.6 to −25.2) | −2.5 (−4.7 to −0.3) |
| Glucose | 63 292 | 16.7 (16.3 to 17.1) | 8.3 (7.2 to 9.4) | 11.3 (9.7 to 12.9) | 3.2 (2.3 to 4.2) | 12 098 | 9.4 (8.7 to 10.2) | −3.1 (−4.4 to −1.8) | −3.6 (−5.5 to −1.6) | −2.7 (−4.1 to −1.3) |
| Any CVRF | 90 060 | 54.1 (53.7 to 54.6) | −4.0 (−5.1 to −2.9) | −2.2 (−3.8 to −0.6) | 2.6 (1.6 to 3.5) | 48 683 | 34.1 (33.5 to 34.6) | −22.2 (−23.3 to −21.1) | −23.3 (−24.9 to −21.8) | −5.4 (−6.6 to −4.2) |
Abbreviations: ADT, androgen deprivation therapy; ASCVD, atherosclerotic cardiovascular disease; CVRF, cardiovascular risk factor.
a
Adjusted proportion of patients in the reference group (No ASCVD, No ADT) with recorded measurements who have uncontrolled CVRFs.
b
Adjusted for race, age, poverty index, disease stage, and year. Risk difference coefficients are interpreted as absolute percent change in the risk of outcome.
c
Adjusted proportion of patients in the reference group (No ASCVD, No ADT) with uncontrolled CVRFs who are not on a corresponding risk-reducing medication.